|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 841.39 USD | +0.01% |
|
+4.40% | +2.57% |
| 07-14 | Cheniere appoints former McKesson CFO to board | RE |
| 07-14 | Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Pharmaceuticals Wholesale
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 98.51B | |||||
| 53.52B | |||||
| 23.53B | |||||
| 8.25B | |||||
| 7.79B | |||||
| 6.99B |
- Stock Market
- Stocks
- MCK Stock
- Charts McKesson Corporation
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
